Genetically engineered mice have greatly improved our understanding of gene functions and disease mechanisms. Nevertheless, the traditional knock-out approach has limitations in the overall viability of mutants. The application of the Cre/loxP system in the inner ear can help bypass this difficulty by generation of conditional gene recombineering. However, to do so requires an expression system that allows ear-specific temporally inducible, gene abrogation of one or more of the increasingly available floxed genes. To date, three approaches have been successfully used to create murine inner ear-specific Cre lines: conventional transgenesis, BAC transgenesis, and gene knock-in. Unfortunately, timing of conditional Cre activity does not extend beyond the regulatory range of the gene controlling Cre expression. Rectification of this problem requires the generation of tamoxifen or tetracycline inducible systems in the inner ear. Examination of integrase expression at different loci will facilitate studies on the expression of exogenous transgenes. These genetic applications for the mouse genome will dramatically advance in vivo gene function studies.
KeywordsRecombineering; Recombinase; Integrase; Transgene; Inducible; Inner ear
Importance of developing recombineering mouse lines in inner earGenetically engineered mice have greatly improved our understanding of gene functions and disease mechanisms, thereby enhancing translational research Liberman et al., 2004;Zuo, 2002). While of great value, genetically engineered mice also have limitations. Such limits include embryonic lethality, leaky expression, chromosomal insertional and positional variations, strain background effects, and biological redundancy. It is demonstrated that 15-20% of germline mutations result in embryonic lethal phenotypes (Zambrowicz et al., 2003). Some of these limitations relate to the use of ubiquitous promoters to create gain-of-function (GOF) transgenic mice as well as a wider expression pattern of a gene-of-interest (GOI) or the use of a gene's endogenous promoter to examine loss-of-function (LOF) by knock-out strategies or GOF and misexpression using knock-in techniques. Much needed, more restricted expression was achieved by incorporating gene promoter cis elements into transgenic construct design using mammalian and
NIH Public Access
NIH-PA Author ManuscriptNIH-PA Author Manuscript NIH-PA Author Manuscript nonmammalian recombination systems. These advanced systems include noneukaryotic recombinases for excision of targeted genes, inducibility using tetracycline or tamoxifen treatments, and, most recently, transposon technology (Albanese et al., 2002;Groth and Calos, 2004;Heine et al., 2005;Izsvak and Ivics, 2004;Liu et al., 2003;Ristevski, 2005;Tian et al., 2004). Inducible switches provide experimental and therapeutic avenues for both qualitative and quantitative regulation of gene expression and manipulation of gene networks or modules. Finely controlled gene expression circuitries should increase development of successful ...